Patients are finding it increasingly difficult to acquire drugs in the market, and the main reason behind the problems regarding drug supplies is the currency rates, Nurten Saydan, the head of the Employer Pharmacists’ Association (TEİS), has said.
The Turkish Lira has weakened sharply against major currencies, including the U.S. dollar and euro, over the past year.
Saydan has warned that unless the state updates its currency rate against the euro by the end of the year certain drugs such as pain killers, influenza vaccines, blood pressure medications, eye drops, and COPD (Chronic obstructive pulmonary disease) and diabetes drugs may be off the shelves soon.
CHP EU Representation - Brussels 